Avoiding allogenic blood transfusions in endoscopic angiofibroma surgery

Table 1 Summary of results

Patient	Age	Tumour stage Fisch	Intraoperative blood loss (ml)	Cell saver blood transfusion	Nasal swab	Cell saver blood culture	Postoperative blood culture
Patient 1	12	2	500 ml	200 ml	Staphylococcus Aureus	No growth	No growth
Patient 2	19	2	500 ml	300 ml	Staphylococcus Aureus	No growth	No growth
Patient 3	18	3	1700 ml	700 ml	Staphylococcus Aureus	No growth	No growth
Patient 4 No LDF	13	3	2000 ml	1500 ml	Staphylococcus Aureus	Staphylococcus Aureus	Staphylococcus Aureus
Patient 5 Johavah’s Witness	16	3	4000 ml	2500 ml	Streptococcus Viridans	No growth	No growth
Patient 6	14	3	3000 ml	1700 ml	Methicillinresistant Staphylococcus Aureus (MRSA)	No growth	No growth
Patient 7	15	2	1000 ml	600 ml	Staphylococcus Epidermidis	No growth	No growth
Patient 8	13	2	900 ml	400 ml	Streptococcus Viridans	No growth	No growth
Patient 9	16	2	1000 ml	600 ml	Moraxella Catarrhalis	No growth	No growth
Patient 10 No LDF	14	2	700 ml	250 ml	Staphylococcus Aureus	Staphylococcus Aureus	Staphylococcus Aureus

ISSN: 1916-0216